Is angelinipharma.es Safe? Security Analysis for Angelini Pharma
https://angelinipharma.esCheck if angelinipharma.es is a scam or legitimate. Free security scan and reviews.
Above Healthcare avg (65)
10,000+
Domains scanned
500+
Security teams trust us
EveryPay
Secure checkout
Instant
Reports delivered
Get the professional PDF report for angelinipharma.es
Export this security analysis as a professional PDF document, receive it via email, and access marketing intelligence data including contact emails and phone numbers. One-time purchase for lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
AI Summary
Angelini Pharma España is a large, international healthcare company specializing in pharmaceutical products with a strong focus on mental health, central nervous system disorders, pain management, rare diseases, and consumer healthcare products. The company operates as a subsidiary of Angelini S.p.a. and maintains a significant presence across multiple European countries and the USA. Their website reflects a professional and consistent brand image, targeting healthcare professionals and consumers interested in health solutions. The site offers comprehensive information about their therapeutic areas, pipeline, partnerships, and corporate responsibility initiatives. Technically, the website employs modern JavaScript libraries such as jQuery, Slick Carousel, and Magnific Popup, alongside Piwik PRO for analytics and cookie consent management. The site is mobile-optimized with good SEO and accessibility features, although some accessibility and security headers could be improved. Hosting details are not explicitly disclosed but the infrastructure appears stable and performant. From a security perspective, the site uses HTTPS with good SSL configuration and implements cookie consent mechanisms aligned with GDPR requirements. However, explicit security policies, incident response contacts, and vulnerability disclosure mechanisms are not present, which could be areas for enhancement. No critical vulnerabilities or suspicious patterns were detected in the content or WHOIS data. Overall, Angelini Pharma España presents a trustworthy, professional, and compliant digital presence suitable for its industry and audience. Strategic improvements in security headers and transparency policies would further strengthen its security posture and user trust.
Detected Technologies
9 urgent findings need attention
9 high
- + 1 more findings in the full report below
Keep angelinipharma.es under constant watch
Guard tracks your live infrastructure daily: certificate expiry, DNS & mail authentication drift, uptime changes, subdomain inventory, and unexpected tracker or content shifts. A full timeline captures every diff so you can prove remediation and spot regressions instantly.
Security drift alerts
Risk score drops, new high-severity issues, and header hardening gaps
Compliance watch
GDPR / NIS2 posture changes with governance evidence snapshots
Infrastructure surface
Unexpected open services, SSL expiry, DNS & email authentication changes
Content & tracker intelligence
Marketing tech shifts, analytics drift, and AI recommendation updates
Cancel anytime. Alerts sent to the contacts you choose. Unlock the full report to view historical timelines and alerts.
Security Headers
2 findings
90/100
GDPR Compliance
3 findings
68/100
NIS2 Compliance
9 findings
2/100
Email Security
3 findings
45/100
🧠AI Business Intelligence
Technology stack, business insights, and market analysis powered by AI.
Business Intelligence
Market & Strategic Analysis
Angelini Pharma holds a strong market position as an international leader in healthcare, particularly in mental health and consumer health sectors. Their business model revolves around pharmaceutical manufacturing, research and development, and distribution of prescription and OTC products. The company targets healthcare professionals, patients, and consumers, leveraging a broad portfolio of brands and therapeutic areas. Their extensive partnership network and multiple country-specific subsidiaries indicate a well-established and diversified operational footprint. The presence of certifications like Top Employer Spain and Europe 2025 further supports their credibility and commitment to quality. The website content and structure reflect a mature organization with clear strategic focus and growth potential.
Security Posture Analysis
Comprehensive Security Assessment
The website demonstrates a mature security posture with enforced HTTPS, cookie consent management, and anonymized analytics tracking. However, the absence of explicit security policies, incident response contacts, and vulnerability disclosure mechanisms indicates room for improvement in transparency and preparedness. Security headers such as Content-Security-Policy, X-Frame-Options, and X-Content-Type-Options are not explicitly detected, which are recommended best practices to mitigate common web vulnerabilities. No exposed sensitive data or vulnerable libraries were found. Overall, the security posture is good but could be enhanced by adopting additional security headers and publishing formal security policies.
Strategic Recommendations
Priority Actions for Security Improvement
Implement and enforce Content-Security-Policy, X-Frame-Options, and X-Content-Type-Options HTTP headers to improve protection against common web attacks.
✨Observations
AI-powered comprehensive website and business analysis.
AI-Enhanced Website Analysis
Business Insights
Angelini Pharma
Grupo internacional líder en atención sanitaria, con especial fuerza y experiencia en el área de la Salud Mental, así como en medicamentos OTC. Angelini Pharma se compromete a identificar soluciones de salud con un enfoque predominante en las áreas del Sistema Nervioso Central (SNC), incluido el dolor y las Enfermedades Raras. La Compañía también es líder en el sector Consumer Health.
good
consistent
Technical Stack
moderate
good
basic
good
Security Assessment
- HTTPS enforced
- Cookie consent mechanism implemented
- No exposed sensitive data in HTML
- Use of analytics with anonymization options
Analytics & Tracking
Advertising & Marketing
Website Quality Assessment
Key Observations
Website is fully accessible with no blocking or WAF challenges.
Get this report delivered to your inbox
Receive a summary of the angelinipharma.es security findings by email. Quick and easy to share with decision makers.
🛡️Security Headers
HTTP security headers analysis and recommendations.
Security Headers
HTTP security headers analysis
Weak Referrer-Policy configuration
LOWCurrent value: "no-referrer-when-downgrade"
Sensitive data may be cached
LOWCache-Control header should include "no-store" for sensitive pages
👤GDPR Compliance
Privacy and data protection assessment under GDPR regulations.
GDPR Compliance
Privacy and data protection assessment
No Cookie Consent Banner found
HIGHGDPR requires explicit consent for non-essential cookies
No Data Protection Officer mentioned
LOWLarge organizations may need to designate a DPO under GDPR
Privacy policy may not be GDPR compliant
MEDIUMPrivacy policy lacks explicit GDPR compliance elements
GDPR Compliance Analysis
🛡️NIS2 Compliance
Network & Information Security Directive compliance assessment.
NIS2 Compliance
Network & Information Security Directive
No information security framework found
HIGHNIS2 requires documented cybersecurity and information security measures
No vulnerability disclosure policy
MEDIUMNIS2 encourages coordinated vulnerability disclosure
No security policy documentation found
HIGHNIS2 requires documented cybersecurity governance and risk management
No incident response procedures found
HIGHNIS2 requires documented incident response and business continuity plans
No business continuity planning found
MEDIUMNIS2 emphasizes operational resilience and business continuity
No security contact information
HIGHNIS2 requires clear incident reporting channels
No vulnerability reporting mechanism
MEDIUMClear vulnerability reporting supports coordinated disclosure
No NIS2 reference found
LOWConsider explicitly mentioning NIS2 compliance efforts
Critical sector without clear security compliance
HIGHDetected sectors: energy, transport, health, digital
Need this report as a PDF?
Download the complete angelinipharma.es security analysis as a professional PDF. Share it with your team, clients, or stakeholders.
📧Email Security
SPF, DKIM, and DMARC validation and email security assessment.
Email Security
SPF, DKIM, and DMARC validation
No SPF record found
HIGHSPF helps prevent email spoofing
No DMARC record found
HIGHDMARC provides email authentication and reporting
No DKIM record found
MEDIUMDKIM adds cryptographic signatures to emails
DMARC Details
MTA-STS Details
🏆SSL/TLS Security
Certificate validity and encryption analysis.
SSL/TLS Security
Certificate validity and encryption analysis
Weak Protocols Supported
HIGHServer supports weak protocols: TLSv1.1
Certificate Transparency Not Implemented
LOWCertificate is not logged in Certificate Transparency logs
Partial SSL/TLS Assessment
LOWCompleted 3 of 4 security checks due to time constraints
Protocol Support
OCSP Status
📊DNS Health
DNS configuration and security assessment.
DNS Health
DNS configuration and security assessment
DNSSEC Not Enabled
MEDIUMDNSSEC is not configured for this domain
CAA Records Not Configured
LOWCertificate Authority Authorization (CAA) records not found
DNS Records
DNSSEC Status
DNS Performance
⚡Network Security
Port scanning and network exposure analysis.
Network Security
Port scanning and network exposure analysis
Good Network Security Posture
LOWNo unnecessary services detected on common risky ports
How does angelinipharma.es compare?
See how angelinipharma.es stacks up against similar websites in the same industry.
🔧Technical Analysis
Detailed technical findings and analysis from AI assessment.
Technical Analysis
Comprehensive security assessment findings
Additional Findings
Download the angelinipharma.es report as PDF
Get the complete analysis in a shareable PDF format, delivered instantly to your email with lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
Scan your own website
Liked the angelinipharma.es report? Run the same comprehensive security analysis on your domain — free, instant, and no sign-up required.
Or browse our directory of >10,000 scanned websites.
How did we do?
Your feedback directly shapes our roadmap. Rate the quality of this report, leave an optional comment, and let us know if you want our security specialists to follow up.
What others say about angelinipharma.es
Share your experience to help others make informed decisions. We verify every review by email and publish it once our moderation team approves it.
Community rating
—out of 5
0 reviews published